Mesoblast Limited

MESO ·Healthcare, Drug Manufacturers - General, Australia
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $662.1M

Liabilities Breakdown FY2022

Total Liabilities: $165.1M